intertissue limited

NR

intertissue limited Company Information

Share INTERTISSUE LIMITED
Live 
Mature

Company Number

04537324

Registered Address

brunel way baglan energy park, briton ferry, neath, SA11 2FP

Industry

Manufacture of paper and paperboard

 

Telephone

01204673300

Next Accounts Due

September 2024

Group Structure

View All

Directors

Luigi Lazzareschi21 Years

Edilio Stefani3 Years

Shareholders

sofidel spa 100%

intertissue limited Estimated Valuation

£0

Pomanda estimates the enterprise value of INTERTISSUE LIMITED at £0 based on a Turnover of £0 and 0.35x industry multiple (adjusted for size and gross margin).

intertissue limited Estimated Valuation

£0

Pomanda estimates the enterprise value of INTERTISSUE LIMITED at £0 based on an EBITDA of £0 and a 2.79x industry multiple (adjusted for size and gross margin).

intertissue limited Estimated Valuation

£452.1k

Pomanda estimates the enterprise value of INTERTISSUE LIMITED at £452.1k based on Net Assets of £299k and 1.51x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Intertissue Limited Overview

Intertissue Limited is a live company located in neath, SA11 2FP with a Companies House number of 04537324. It operates in the manufacture of paper and paperboard sector, SIC Code 17120. Founded in September 2002, it's largest shareholder is sofidel spa with a 100% stake. Intertissue Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Intertissue Limited Health Check

There is insufficient data available to calculate a health check for Intertissue Limited. Company Health Check FAQs

Health Check Image
Health Rating0out of 5
positive_score

0 Strong

positive_score

0 Regular

positive_score

0 Weak

size

Size

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

growth

Growth

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

production

Production

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

profitability

Profitability

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

employees

Employees

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

paystructure

Pay Structure

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

efficiency

Efficiency

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

debtlevel

Debt Level

There is insufficient data available for this Key Performance Indicator!

- - Intertissue Limited

- - Industry AVG

INTERTISSUE LIMITED financials

EXPORTms excel logo

Intertissue Limited's latest turnover from December 2022 is estimated at 0 and the company has net assets of £299 thousand. According to their latest financial statements, we estimate that Intertissue Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover00059,071,000128,889,000131,903,000133,628,000130,654,000149,412,000150,501,00094,580,657126,683,05699,901,35887,806,319
Other Income Or Grants00000000000000
Cost Of Sales00046,365,00098,068,000102,909,000105,234,000104,033,000122,076,000121,404,00079,609,25989,760,35464,567,89056,624,265
Gross Profit00012,706,00030,821,00028,994,00028,394,00026,621,00027,336,00029,097,00014,971,39836,922,70235,333,46831,182,054
Admin Expenses0006,068,00022,011,00026,862,00024,727,00020,242,00016,774,00021,897,0007,050,00615,474,79715,785,6957,562,171
Operating Profit0006,638,0008,810,0002,132,0003,667,0006,379,00010,562,0007,200,0007,921,39221,447,90519,547,77323,619,883
Interest Payable000434,000117,000206,000339,000518,000557,000676,0001,000,4011,164,9231,218,1992,704,460
Interest Receivable0002,0001,0008,00058,00073,0007,000180,00072,519140,98155,95258,988
Pre-Tax Profit0006,212,0007,810,0001,967,0003,392,0005,821,00010,012,0006,704,0006,993,51020,423,96318,385,52620,974,411
Tax000-1,294,000-1,776,000-739,000-804,000-1,066,000-2,433,000-1,496,000-1,665,703-5,150,250-5,137,911-2,768,185
Profit After Tax0004,918,0006,034,0001,228,0002,588,0004,755,0007,579,0005,208,0005,327,80715,273,71313,247,61518,206,226
Dividends Paid00086,250,00000011,000,000000000
Retained Profit000-81,332,0006,034,0001,228,0002,588,000-6,245,0007,579,0005,208,0005,327,80715,273,71313,247,61518,206,226
Employee Costs0005,787,00012,756,00014,268,00015,322,00015,197,00016,480,00015,636,00010,545,28510,299,7209,574,0049,481,718
Number Of Employees001321362411437446447439302300293297
EBITDA*0009,402,00014,615,0008,684,00011,308,00014,313,00018,063,00014,005,0008,472,58427,304,02525,156,88129,145,093

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets000059,734,00064,265,00076,812,00071,043,00077,442,00078,404,00074,462,82878,976,12281,014,12483,384,055
Intangible Assets00001,937,0001,938,0001,940,0001,941,0001,939,0001,937,0000000
Investments & Other00002,307,0005,102,00000000000
Debtors (Due After 1 year)0000000000001,224,0001,430,000
Total Fixed Assets000063,978,00071,305,00078,752,00072,984,00079,381,00080,341,00074,462,82878,976,12282,238,12484,814,055
Stock & work in progress000020,912,00020,346,00022,720,00021,645,00020,884,00021,963,00014,905,27617,368,89313,539,64312,523,650
Trade Debtors00001,239,0003,196,0001,351,0003,390,00013,733,00014,468,0003,906,13321,965,36617,642,87813,361,297
Group Debtors299,000299,000299,000299,00022,917,00010,094,00014,987,00020,956,00016,484,00021,387,00030,466,73211,986,8215,675,1410
Misc Debtors0000570,000702,000841,0001,136,0001,030,0001,551,00068,87693,074269,19933,560
Cash00008,105,0001,522,0001,201,000741,0004,558,000662,0001,034,5606,139,6722,686,0123,203,547
misc current assets00000000000000
total current assets299,000299,000299,000299,00053,743,00035,860,00041,100,00047,868,00056,689,00060,031,00050,381,57757,553,82639,812,87329,122,054
total assets299,000299,000299,000299,000117,721,000107,165,000119,852,000120,852,000136,070,000140,372,000124,844,405136,529,948122,050,997113,936,109
Bank overdraft0000003,232,000564,0000001,106,7722,039,7756,818,843
Bank loan0000007,902,0007,737,0007,560,0006,580,0000000
Trade Creditors 000015,675,00012,000,00014,281,0008,435,0007,056,0007,587,0002,797,4187,482,0585,211,5865,258,071
Group/Directors Accounts00008,873,0007,688,0009,158,00012,841,0007,703,0008,520,0002,267,4004,318,8532,563,485313,006
other short term finances0000006,000422,000778,000682,0006,423,1715,596,9438,863,3517,669,508
hp & lease commitments00000000000000
other current liabilities00004,167,0003,066,0003,552,0003,771,00010,540,00011,006,0006,362,0088,711,3645,925,3835,325,050
total current liabilities000028,715,00022,754,00038,131,00033,770,00033,637,00034,375,00017,849,99727,215,99024,603,58025,384,478
loans00000007,980,00016,155,00026,825,00031,771,59338,255,36841,004,81850,011,564
hp & lease commitments00000000000000
Accruals and Deferred Income00000000004,941,4345,408,7605,876,0876,343,414
other liabilities0000003,072,0000000000
provisions00005,230,0006,209,0004,123,0003,627,0004,247,0004,252,0005,042,9865,739,2425,929,637807,393
total long term liabilities00005,230,0006,209,0007,195,00011,607,00020,402,00031,077,00041,756,01349,403,37052,810,54257,162,371
total liabilities000033,945,00028,963,00045,326,00045,377,00054,039,00065,452,00059,606,01076,619,36077,414,12282,546,849
net assets299,000299,000299,000299,00083,776,00078,202,00074,526,00075,475,00082,031,00074,920,00065,238,39559,910,58844,636,87531,389,260
total shareholders funds299,000299,000299,000299,00083,776,00078,202,00074,526,00075,475,00082,031,00074,920,00065,238,39559,910,58844,636,87531,389,260
Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit0006,638,0008,810,0002,132,0003,667,0006,379,00010,562,0007,200,0007,921,39221,447,90519,547,77323,619,883
Depreciation0002,764,0005,804,0006,550,0007,638,0007,932,0007,499,0006,605,000551,1925,856,1205,609,1085,525,210
Amortisation00001,0002,0003,0002,0002,000200,0000000
Tax000-1,294,000-1,776,000-739,000-804,000-1,066,000-2,433,000-1,496,000-1,665,703-5,150,250-5,137,911-2,768,185
Stock000-20,912,000566,000-2,374,0001,075,000761,000-1,079,0007,057,724-2,463,6173,829,2501,015,99312,523,650
Debtors000-24,427,00010,734,000-3,187,000-8,303,000-5,765,000-6,159,0002,964,259396,4809,234,0439,986,36114,824,857
Creditors000-15,675,0003,675,000-2,281,0005,846,0001,379,000-531,0004,789,582-4,684,6402,270,472-46,4855,258,071
Accruals and Deferred Income000-4,167,0001,101,000-486,000-219,000-6,769,000-466,000-297,442-2,816,6822,318,654133,00611,668,464
Deferred Taxes & Provisions000-5,230,000-979,0002,086,000496,000-620,000-5,000-790,986-696,256-190,3955,122,244807,393
Cash flow from operations00028,375,0005,336,00012,825,00023,855,00012,241,00021,866,0006,188,171676,44013,489,21314,225,38116,762,329
Investing Activities
capital expenditure00058,907,000-1,273,0005,997,000-13,409,000-1,537,000-6,541,000-12,683,1723,962,102-3,818,118-3,239,177-88,909,265
Change in Investments000-2,307,000-2,795,0005,102,00000000000
cash flow from investments00061,214,0001,522,000895,000-13,409,000-1,537,000-6,541,000-12,683,1723,962,102-3,818,118-3,239,177-88,909,265
Financing Activities
Bank loans00000-7,902,000165,000177,000980,0006,580,0000000
Group/Directors Accounts000-8,873,0001,185,000-1,470,000-3,683,0005,138,000-817,0006,252,600-2,051,4531,755,3682,250,479313,006
Other Short Term Loans 00000-6,000-416,000-356,00096,000-5,741,171826,228-3,266,4081,193,8437,669,508
Long term loans000000-7,980,000-8,175,000-10,670,000-4,946,593-6,483,775-2,749,450-9,006,74650,011,564
Hire Purchase and Lease Commitments00000000000000
other long term liabilities00000-3,072,0003,072,0000000000
share issue000-2,145,000-460,0002,448,000-3,537,000-311,000-468,0004,473,60500013,183,034
interest000-432,000-116,000-198,000-281,000-445,000-550,000-496,000-927,882-1,023,942-1,162,247-2,645,472
cash flow from financing000-11,450,000609,000-10,200,000-12,660,000-3,972,000-11,429,0006,122,441-8,636,882-5,284,432-6,724,67168,531,640
cash and cash equivalents
cash000-8,105,0006,583,000321,000460,000-3,817,0003,896,000-372,560-5,105,1123,453,660-517,5353,203,547
overdraft00000-3,232,0002,668,000564,00000-1,106,772-933,003-4,779,0686,818,843
change in cash000-8,105,0006,583,0003,553,000-2,208,000-4,381,0003,896,000-372,560-3,998,3404,386,6634,261,533-3,615,296

intertissue limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for intertissue limited. Get real-time insights into intertissue limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Intertissue Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for intertissue limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

intertissue limited Ownership

INTERTISSUE LIMITED group structure

Intertissue Limited has no subsidiary companies.

Ultimate parent company

SOFIDEL SPA

#0047462

1 parent

INTERTISSUE LIMITED

04537324

INTERTISSUE LIMITED Shareholders

sofidel spa 100%

intertissue limited directors

Intertissue Limited currently has 2 directors. The longest serving directors include Mr Luigi Lazzareschi (Sep 2002) and Mr Edilio Stefani (Jan 2021).

officercountryagestartendrole
Mr Luigi Lazzareschi61 years Sep 2002- Director
Mr Edilio StefaniWales64 years Jan 2021- Director

P&L

December 2022

turnover

0

0%

operating profit

0

0%

gross margin

0%

0%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2022

net assets

299k

0%

total assets

299k

0%

cash

0

0%

net assets

Total assets minus all liabilities

intertissue limited company details

company number

04537324

Type

Private limited with Share Capital

industry

17120 - Manufacture of paper and paperboard

incorporation date

September 2002

age

22

accounts

Dormant

ultimate parent company

SOFIDEL SPA

previous names

N/A

incorporated

UK

address

brunel way baglan energy park, briton ferry, neath, SA11 2FP

last accounts submitted

December 2022

intertissue limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 3 charges/mortgages relating to intertissue limited. Currently there are 1 open charges and 2 have been satisfied in the past.

charges

intertissue limited Companies House Filings - See Documents

datedescriptionview/download